For partners

Bring us the molecules that delivery or stability are holding back.

If a promising active fails on stability, cannot reach its target tissue, or cannot be given locally without systemic exposure, that is the problem rT64 NanoEmitters were built to solve. We are the enabling formulation, so you keep your molecule and your program, and add the capability that was missing.

Who we work with today

Programs running now.

Across skincare, longevity and contract manufacturing.

UNITED STATES US Longevity Skincare Brand
UNITED STATES US Novel Skincare Brand
EUROPE Large European CDMO
KOREA Korean Longevity Skincare Brand
ASIA Large Japanese Cosmetic Brand
What we solve

The three walls large molecules run into.

Proteins, peptides, RNA and other novel molecules offer greater precision and potency, but are held back by three core problems. NanoEmitters address all three in one formulation.

Stability

It degrades before it is used

Actives that break down in weeks force a cold chain and shorten shelf life. NanoEmitters hold stability at room temperature for months, which simplifies your logistics and widens where the product can go.

Penetration

It cannot reach the target

Large molecules stall at the tissue surface or never reach the deep interior. NanoEmitters actively drive cargo into tissue, so the active arrives where it is meant to act.

Exposure

It cannot be kept local

Delivering to one site without dosing the whole body is unsolved across modalities. For a small molecule that already crosses easily, it is often the only wall left. NanoEmitters concentrate release in the target region and keep systemic levels low.

How an engagement works

A staged path from feasibility to supply.

We start with initial feasibility studies to demonstrate your core objectives for your molecule, then scale the relationship as the data advances.

01

Feasibility

We assess your active and target tissue with our initial NanoEmitter formulation and define what success looks like up front.

02

Optimization

We build and optimize a custom NanoEmitter formulation for your molecule using approved materials and your existing formats.

03

Translation

Organize an early consumer or preclinical testing package for safety and efficacy.

04

Scale and license

Engage in supply, licensing and milestone agreements that fit efficiently into your business and operations.

Team experience spans

Alnylam Pfizer Roche Johnson & Johnson Ferring Pharmaceuticals Pentax Medical
Let's connect

Tell us what delivery is blocking.

Share with us the molecule, the target tissue and the formulation hurdles you are trying to overcome. If delivery or stability are what parked the program, you have come to the right place.

Get in touch